• Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Intelligence
    • Policy Intelligence
    • Security Intelligence
    • Economic Intelligence
    • Fashion Intelligence
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • LBNN Blueprints
Home Technology

GSK’s 5-in-1 meningococcal shot wins FDA approval

Simon Osuji by Simon Osuji
February 18, 2025
in Technology
0
GSK’s 5-in-1 meningococcal shot wins FDA approval
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through 25 years old.

Source link

Previous Post

China-Africa Energy Investment and Cooperation to be Showcased at Investor Forum in Shanghai

Next Post

Uncertainty mounts at Space Development Agency as Air Force IG prepares probe

Next Post
Uncertainty mounts at Space Development Agency as Air Force IG prepares probe

Uncertainty mounts at Space Development Agency as Air Force IG prepares probe

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR NEWS

  • Mahama attends Liberia’s 178th independence anniversary

    Mahama attends Liberia’s 178th independence anniversary

    0 shares
    Share 0 Tweet 0
  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0
  • The world’s top 10 most valuable car brands in 2025

    0 shares
    Share 0 Tweet 0
  • Top 10 African countries with the highest GDP per capita in 2025

    0 shares
    Share 0 Tweet 0
  • Global ranking of Top 5 smartphone brands in Q3, 2024

    0 shares
    Share 0 Tweet 0

Get strategic intelligence you won’t find anywhere else. Subscribe to the Limitless Beliefs Newsletter for monthly insights on overlooked business opportunities across Africa.

Subscription Form

© 2026 LBNN – All rights reserved.

Privacy Policy | About Us | Contact

Tiktok Youtube Telegram Instagram Linkedin X-twitter
No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • LBNN Blueprints
  • Quizzes
    • Enneagram quiz
  • Fashion Intelligence

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.